Clopidogrel Loading Dose 300 vs. 600 mg in Patients Undergoing One-Stop Hybrid Coronary Revascularization: A Prospective Single-Center Randomized Pilot Study

Background: The optimal loading dose of clopidogrel in one-stop hybrid coronary revascularization (HCR) remains an “evidence-free” zone. This study aimed to compare the major bleeding and ischemic thrombotic events between different clopidogrel loading doses (300 vs. 600 mg) in one-stop HCR. Methods...

Descripción completa

Detalles Bibliográficos
Autores principales: Guo, Yulin, Li, Dongjie, Gao, Yingdi, Zhao, Jing, An, Xiangguang, Liu, Yan, Gu, Song, Zhang, Xitao, Gao, Jie, Su, Pixiong
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2021
Materias:
Surgery
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8554050/
https://www.ncbi.nlm.nih.gov/pubmed/34722627
http://dx.doi.org/10.3389/fsurg.2021.768860

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8554050/
https://www.ncbi.nlm.nih.gov/pubmed/34722627
http://dx.doi.org/10.3389/fsurg.2021.768860

Ejemplares similares